Some adults who have advanced renal cell carcinoma (kidney cancer) may receive VotrientTM (pazopanib). It works by blocking certain enzymes in the body that are responsible for causing the cancer cells to grow and multiply. This medication comes in the form of a tablet that is taken once daily on an empty stomach.
While most people tolerate this prescription medicine well, side effects can occur and may include nausea, diarrhea, and loss of appetite. However, in most cases, reactions to this drug are minor and generally easy to treat.
Before taking Votrient, update your healthcare provider on any information regarding other medications you are taking (including vitamins and supplements), as well as any allergies you may have. It is also important to let your healthcare provider know if you are pregnant or breastfeeding.
(For more information on this medication, click Votrient. This full-length article offers more details on how this drug works, dosing guidelines, and general safety precautions to be aware of before beginning treatment.)
Written by/reviewed by: Arthur Schoenstadt, MD
Last reviewed by: ArthurSchoenstadt, MD
List of references (click here):
Votrient [package insert]. Research Triangle Park, NC: GlaxoSmithKline;2010 April.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed October 7, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click